EDIT:NASDAQ
Editas Medicine Inc
2,17 $
arrow_upward
+1,40%(+0,030) 1D
13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
TradingKey
·
7 ժամ առաջ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
6 ժամ առաջ
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc